openPR Logo
Press release

Phenylketonuria Treatment Market Poised to Expand at a Robust Pace Over 2017 – 2025

06-25-2018 12:39 PM CET | Industry, Real Estate & Construction

Press release from: Persistence Market Research

Phenylketonuria Treatment Market Poised to Expand at a Robust

Phenylketonuria, also known as PKU, is a genetic disorder in which, the levels of phenylalanine increases in blood. Phenylalanine is an amino acid (a building block protein), which is obtained from food and diet. Phenylketonuria might lead to seizures, behavioral problems, psychiatric disorder, and delayed development is not treated. Moreover, the increased level of phenylalanine can cause intellectual disability and other health related problems. Children suffering from phenylketonuria might have the musty odor due to the excess phenylalanine in the body. Similarly, the patients tend to have light skin and hair color; and other skin disorders such as eczema. Phenylketonuria vary from mild to severe from, classic PKU is considered as most severe, and variant PKU is a less severe form of the diseases. Children with classic PKU are at the risk of brain damage and requires treatment. However, patients with mild PKU might not need any treatment. PKU suffering babies have low birth weight and slow body growth. Other associated medical problem includes microcephaly, heart problems, and other behavioral problems

Request for Report Sample: https://www.persistencemarketresearch.com/samples/14410

Growing burden of incidence of PKU is major factors driving the growth of global phenylketonuria treatment market. The incidences of PKU varies based on demographics and ethnic groups. In the U.S. PKU affects one among 10,000 to 15,000 newborn babies. Most of these cases are detected by the after the birth screening. The PKU screening test includes bacterial inhibition assay, immunoassay with fluorometric detection, and mass spectrometry for the amino acid measurement.

The global market for phenylketonuria treatment is segmented on basis of product type, route of administration, distribution channel, and geography.

Based on the product of type, the phenylketonuria treatment market is segmented into drugs and nutrition supplements. For the treatment of phenylketonuria, nutrition supplements are widely prescribed by healthcare professionals along with some diet modification. There only few companies which are dealing with the manufacturing of drugs used for the treatment of phenylketonuria. In 2007, Kuvan (sapropterin dihydrochloride), manufactured by BioMarin was approved by Food and Drug Administration (FDA) for the treatment of phenylketonuria in U.S. Kuvan is available in tablet and powder form. The tablet form of drugs is approved in the U.S. European Union, and Canada; and powdered form is approved in U.S. The powdered form of the drug was approved in 2013. Similarly, in 2008, Biopten, manufactured by Daiichi Sankyo Company, Limited was approved in Japan for phenylketonuria treatment.

Request for Report TOC: https://www.persistencemarketresearch.com/toc/14410

Based on the route of administration, the market segmented into an oral route and parenteral route. In phenylketonuria treatment market, the oral route is more preferred mainly due to patient’s convenience and ease of administration. However, intravenous injections/ infusions are difficult to administer. To avoid administration difficulties various companies are developing oral drug formulations of drugs to increase ease of administration.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Phenylketonuria Treatment Market Poised to Expand at a Robust Pace Over 2017 – 2025 here

News-ID: 1096121 • Views:

More Releases from Persistence Market Research

Lipid Nanoparticle Manufacturing Market Analysis and Forecast Report by Persistence Market Research
Lipid Nanoparticle Manufacturing Market Analysis and Forecast Report by Persiste …
The global lipid nanoparticle manufacturing market is witnessing remarkable momentum, driven by advancements in drug delivery technologies and expanding applications in RNA therapeutics. According to Persistence Market Research, the market was valued at US$814.2 million in 2023 and is projected to reach US$1.8 billion by 2031, registering a robust CAGR of 10.4% between 2024 and 2031. This growth reflects the rising demand for efficient delivery platforms for mRNA vaccines, gene
Regenerative Medicine Market Growth Outlook - Persistence Market Research Report
Regenerative Medicine Market Growth Outlook - Persistence Market Research Report
The global regenerative medicine market is undergoing a transformative phase, driven by technological advancements and rising demand for innovative therapies. According to Persistence Market Research, the market is projected to reach US$109.4 Mn by 2031, up from US$32.3 Mn in 2024, registering a CAGR of 19.1% between 2024 and 2031. The industry is witnessing remarkable growth owing to breakthroughs in stem cell therapies, tissue engineering, and gene editing technologies. Cell therapy
Dental Infection Control Products Market Sees Robust Growth, Says Persistence Market Research
Dental Infection Control Products Market Sees Robust Growth, Says Persistence Ma …
The global dental infection control products market is experiencing robust growth, fueled by the rising need for hygiene and infection prevention in dental care. According to Persistence Market Research, the industry is set to expand from a valuation of US$1.7 billion in 2024 to US$2.9 billion by 2031, reflecting a strong CAGR of 7.2%. Increasing demand for sterilization equipment, disinfectants, and protective gear underscores the central role of infection control
mRNA Synthesis and Manufacturing Market Growth Forecast by Persistence Market Research
mRNA Synthesis and Manufacturing Market Growth Forecast by Persistence Market Re …
The mRNA synthesis and manufacturing market has emerged as one of the most dynamic sectors within the biopharmaceutical industry. With applications spanning from vaccines to personalized medicine, the demand for scalable, cost-effective, and high-quality mRNA production has surged significantly. According to Persistence Market Research, the global market is projected to rise from US$52.7 billion in 2023 to US$64.4 billion by 2031, expanding at a CAGR of 2.5% during 2024-2031. The primary

All 5 Releases


More Releases for PKU

What foods can people eat with PKU? Industry Trends and Best Practices
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-07/what-do-the-8-wires-in-an-ethernet-cable-do-5.jpg Phenylketonuria (PKU) is a rare inherited disorder that causes an amino acid called phenylalanine to build up in the body. PKU is caused by a change in the phenylalanine hydroxylase (PAH) gene, which helps create the enzyme needed to break down phenylalanine. Managing PKU means carefully controlling phenylalanine intake through diet. A Founder's Heart: GuoHong Liu's Journey to SINOFN Imagine a world where the very food you need to survive is
More Than a Cake: SINOFN Launched PKU Health Care Activities
A Sweet Slice of Hope: SINOFN's Commitment to Children with PKU Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-08/weixin-image_2025-08-08_022524_697.jpg For most families, a birthday cake is a simple joy. But for a child with Phenylketonuria (PKU), it represents a significant challenge. PKU is a rare inherited metabolic disorder where the body cannot process an amino acid called phenylalanine, found in most high-protein foods. A strict, lifelong low-protein diet is essential for their health and development. This is a challenge
PKU Market: Early Detection and New Therapies Fueling Future Expansion
The global PKU market is poised for significant growth in the coming years, driven by a rise in newborn screening programs, increasing awareness of the condition, and advancements in treatment options. Market Overview PKU is a rare genetic disorder affecting the body's ability to process the amino acid phenylalanine. If left untreated, it can lead to intellectual disability, seizures, and other neurological complications. Fortunately, early diagnosis and strict adherence to a special
Phenylketonuria (PKU) Market Grow at Exceptional Rate By Top Emerging Key Player …
Phenylketonuria (PKU) Market Research Report LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Phenylketonuria (PKU) Industry Research Report, Growth Trends and Competitive Analysis 2020-2026". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Phenylketonuria (PKU)
Global Phenylketonuria (PKU) Market Status and Outlook (2015-2025)
Market Overview The Phenylketonuria (PKU) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. The global Phenylketonuria (PKU) market size is expected to gain market growth in the forecast period of 2020 to
Phenylketonuria (PKU) Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Phenylketonuria (PKU) market analysis, which studies the Phenylketonuria (PKU)'s industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Phenylketonuria (PKU) Market 2020-2025” Research Report categorizes the global Phenylketonuria (PKU) market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth